Evidence map›Paper›PMID 41016748›Full record

SynthesisInternational journal of epidemiology2025

Body mass index and gastric cancer risk: results from the Stomach Cancer Pooling Project Consortium.

Roberta Pastorino, Denise Pires Marafon, Angelica Valz Gris, Nicolò Lentini, Antonio Cristiano, Nuria Aragonés, Vicente Martín, David Zaridze, Dmistry Maximovich, Jesus Vioque and 16 more

Abstract readMeta-Analysis
In one paragraph

Synthesis in International journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Roberta PastorinoSection of Hygiene, University Department of Health Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Denise Pires MarafonSection of Hygiene, University Department of Health Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Angelica Valz GrisSection of Hygiene, University Department of Health Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0001-7227-2281
Nicolò LentiniSection of Hygiene, University Department of Health Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Antonio CristianoSection of Hygiene, University Department of Health Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.
Nuria AragonésCancer Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.
Vicente MartínConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
David ZaridzeDepartment of Clinical Epidemiology, N.N.Blokhin National Medical Research Center for Oncology, Moscow, Russia.ORCID 0000-0002-2824-3704
Dmistry MaximovichDepartment of Clinical Epidemiology, N.N.Blokhin National Medical Research Center for Oncology, Moscow, Russia.
Jesus VioqueConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Sandra Gonzalez-PalaciosConsortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Reza MalekzadehDigestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-9820-6335
Farhad PourfarziDigestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
Joshua MuscatDepartment of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, PA, United States.
Mary H WardDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
Charles S RabkinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.
Eva NegriDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Rossella BonziDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Carlo PelucchiDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
Paolo BoffettaDepartment of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Maria Costanza CamargoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, United States.ORCID 0000-0002-1065-2198
Maria Paola CuradoCentro Internacional de Pesquisa, A. C. Camargo Cancer Center, São Paulo, Brazil.
Nuno LunetEPIUnit-Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
Zuo-Feng ZhangDepartment of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, United States.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy.ORCID 0000-0003-1441-897X
Stefania BocciaSection of Hygiene, University Department of Health Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, Italy.

Funding

Italian Ministry of Health RF-2021-12373951
6 · The paper itself

Abstract

backgroundBody mass index (BMI) has been associated with gastric cancer (GC), though results are conflicting regarding the GC subsites of cardia and non-cardia. This study aims to evaluate the associations between BMI and GC risk, focusing on these distinct anatomical subsites.

methodsWe pooled data from seven case-control studies from the Stomach Cancer Pooling (StoP) Project. Pooled odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) of GC risk across BMI categories (normal weight, overweight, obesity) were calculated by pooling study-specific ORs through random-effects meta-analytic models. The dose-response relationship between BMI and the risk of GC cancer was assessed by using a one-stage mixed-effects logistic regression model. Results were stratified according to cardia and non-cardia GC.

resultsThe analysis comprised 1478 GC cases, including 511 cardia and 967 non-cardia cases, and 6671 controls. There was an increased risk of cardia GC among obese patients (OR 1.57, 95% CI 1.20-2.06), while no association was found for non-cardia GC (OR 0.82, 95% CI 0.66-1.01). Restricting the analysis to population-based studies, the association for cardia GC became stronger for obese (OR 1.65, 95% CI 1.09-2.48) and overweight (OR 1.62, 95% CI 1.10-2.39) patients. The dose-response meta-analysis showed an increased risk of cardia GC with increasing BMI values, ranging from a null effect at a BMI of 21.75 to an OR of 2.06 (95% CI 1.22-3.48) for a BMI of ≥40.

conclusionOur results indicate an association between higher BMI categories and the risk of cardia GC, whereas no association was found with non-cardia GC.

Indexed as

Body Mass IndexObesityStomach NeoplasmsAdultAgedCardiaCase-Control StudiesFemaleHumansLogistic ModelsMaleMiddle AgedOdds RatioOverweightRisk Factorsbody mass indexcancer preventiongastric cancer

Identifiers

PMID41016748
PMCPMC12476909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.